Financial Health Assessment: Integra Contracts Limited

Patient: Integra Contracts Limited (Company No. 02548215) Age: 35 years since incorporation (12 October 1990) Sector: Construction — other building completion and finishing (SIC 43390); London fit‑out and interiors Last examination: Year ended 31 March 2025 (audited, full accounts) Status: Active — filings current, no insolvency events

1. Financial Health Score: A‑

Sub‑scores

Why A‑ and not A+: This is a genuinely strong company. It just lost its largest client to insolvency, absorbed the hit, and still doubled operating profit and grew cash by 97%. That is a resilient constitution. The deductions are for three things: (a) a £22.3m dividend paid after the year end that removes most of the balance sheet buffer; (b) a margin jump that may not be repeatable; and (c) demonstrated client concentration risk — the patient's immune system has now been tested and found to have a specific vulnerability.

Why not lower: There is no debt, no going‑concern qualification, no overdue filing, no insolvency history, and 35 years of continuous trading. This is not a business in distress. It is a business in excellent condition that has just made a very large withdrawal from its own reserves.

2. Key Vital Signs

The pulse: cash and liquidity

Reading: This is a strong, well‑perfused circulatory system. Cash alone could settle every liability on the balance sheet nearly three times over. The fact that cash exceeds net assets tells you something important about the operating model: the company is substantially funded by its supply chain and/or customer deposits, and it converts receivables into cash quickly. That works beautifully in a growth phase — but it is a model that depends on continued cash conversion.

The metabolism: profitability

Reading: A metabolic rate most contractors would envy. Doubling operating profit while revenue grows 15% means the gain came from margin, not volume — and margin is the harder thing to win. Directors attribute it to "working on high‑end projects." A 32% gross margin is high for specialist fit‑out work, so this is the single metric most worth interrogating (see Diagnosis).

The skeleton: balance sheet and leverage

Reading: The skeleton is solid but the posture has shifted. Liabilities grew 172% year‑on‑year against asset growth of 52% and revenue growth of 15%. The equity ratio fell from 87% to 73%. That is still a conservatively financed balance sheet with no visible borrowings, but the trend line is worth watching — particularly because in construction, rising liabilities usually mean rising subcontractor payables and retentions, which are effectively a form of short‑term debt from your supply chain.

Note also the £7.5m fall in net assets between FY2021 and FY2022, followed by steady rebuild. That pattern — accumulate, distribute, rebuild — appears to be a recurring behaviour rather than a one‑off event.

The long view: 13‑year trajectory

Reading: This is a genuinely impressive long‑term growth record. A tenfold expansion of the asset base over thirteen years, with cash growing even faster, is the signature of a business that has compounded rather than lurched.

The immune system: risk exposure

• Client concentration: The accounts disclose that "our major client ISG" entered administration during the year. All live projects were re‑engaged under new contracts with end users or new main contractors, and the financial implications are "fully accounted for." The recovery was fast and effective — but the exposure was real.
• Sector contagion: The failure of a major main contractor is a sector‑wide symptom, not just a company‑specific one. It signals stress in the construction supply chain that may persist.
• Price risk: Explicitly flagged by the directors given "prevailing macro‑economic factors."
• Credit risk: Mitigated by client credit assessment — but the ISG event shows that even large, apparently creditworthy counterparties can fail.

Hygiene factors: compliance and governance

• Accounts filed, not overdue; confirmation statement current.
• Unqualified audit opinion from TC Group, with an explicit statement that no material uncertainties cast doubt on going concern.
• Four directors and a company secretary, all current, all British — a stable board.
• No director disqualification records identified.
• Emissions intensity improved 24% (1.07 → 0.81 tonnes CO₂e per £m turnover), with fleet electrification underway.

3. Diagnosis

Primary finding: an exceptionally healthy business that has just performed major surgery on itself

The most important number in this entire file is not on the balance sheet. It is in the directors' report:

"Subsequent to the balance sheet date, dividends of £22,297,250 have been paid to the company's shareholders."

That is 87% of net assets at 31 March 2025, paid out between the year end and the 4 December 2025 signing date. Add the £315,000 paid during the year and total distributions reach roughly £22.6m.

Illustrative effect on a static balance sheet:

Two important caveats: this is a static illustration — the company has continued trading and generating cash since, so the real position will be better. And the recipient is Integra Contracts Holding Ltd, which owns more than 75% of the shares, so this is likely a group treasury decision rather than a distress signal.

But the diagnosis stands: the trading entity's financial cushion has been substantially removed. For a construction business this matters more than it would elsewhere, because main contractors, clients and surety providers routinely assess balance sheet strength during prequalification. A thinner balance sheet can quietly reduce the size and number of projects a company is invited to bid for.

Secondary findings

1. The margin improvement needs a differential diagnosis. An eight‑point gross margin jump in one year has several possible causes, and they have very different prognoses: - Structural — a deliberate shift upmarket into higher‑value work. Durable. - Mix — a favourable concentration of high‑end projects in one year. Temporary. - Recovery — favourable settlements or recoveries on ISG‑affected contracts. One‑off. - Under‑provisioning — contract cost estimates that may need topping up later. A latent risk.

The directors attribute it to high‑end projects, which points to the first or second explanation. But a single year is not enough evidence to call it a new baseline.

2. The ISG event was a stress test, and the company passed it. Early re‑engagement with end clients, full re‑contracting of live projects, and no going‑concern qualification is a textbook response. The lesson to bank is that concentration risk is not theoretical for this business — it has already crystallised once.

3. The company is debt‑free and holds interest‑bearing deposits. No borrowings appear in the filings; the directors refer to "interest‑bearing assets arranged at fixed interest rates." For a contractor of this size, that is a genuinely unusual and enviable position. There is no cardiovascular disease here.

4. The balance sheet is now a cash‑and‑payables balance sheet. Non‑cash assets total £6.2m against £9.9m of liabilities — meaning cash is doing the heavy lifting. That is efficient, but it means the company's resilience is concentrated in one place. If cash conversion slows, the cushion thins quickly.

Data limitations (affecting the confidence of this diagnosis)

• No current asset / current liability split, so a true current ratio cannot be calculated.
• No turnover figures for FY2022–FY2024 in the structured data (narrative only).
• No debtor days, WIP balances, retention figures or employee numbers.
• No breakdown of the £9.9m liabilities.
• In FY2020–FY2025, total assets less total liabilities exceeds the stated net assets by roughly £0.3m–£0.6m, suggesting the liabilities field may exclude certain items such as provisions or deferred tax.
• FY2026 accounts (year ended 31 March 2026) are not yet filed — these will show the first full year of trading after the large distribution, and are the single most informative document still to come.

4. Prognosis

Next 12 months — Good

The order pipeline is described as strong in Central London, with a broad existing client base and scope to widen it. The auditor has confirmed going concern with no material uncertainties. Cash generation is robust. Filings are current. On current indicators, the company should trade comfortably.

12–36 months — Good, with two watch items

Watch item 1: margin normalisation. If gross margin reverts toward the 24% seen in FY2024, operating profit on similar revenue would fall from roughly £7.1m to roughly £4m. That is still a healthy business — but it is a materially different one, and it would arrive at the same time as a much thinner balance sheet.

Watch item 2: balance sheet capacity. A £3.3m net asset base constrains the scale of projects the company can credibly bid for, particularly with public sector or blue‑chip clients who apply financial standing tests. The constraint is not cash generation — it is the reported balance sheet.

Structural outlook — Positive

Thirty‑five years of trading, tenfold asset growth, a dominant position in London fit‑out, a debt‑free balance sheet and a proven ability to survive a major client failure. The sector is consolidating — ISG's collapse removes both a competitor and a source of systemic risk. Companies with strong cash positions typically emerge from sector shakeouts in a stronger competitive position. This patient has the constitution to do exactly that.

Overall prognosis: stable to improving, provided the balance sheet is rebuilt and margin quality is understood.

5. Recommendations

Immediate (next 6 months)

1. Set a formal capital retention policy. Agree a minimum net asset floor — for a business of this scale, something in the region of £10m–£12m would restore meaningful prequalification capacity — and a minimum cash buffer. Distributions should be calculated after those floors are met, not before.
2. Quantify the margin gain. Split the FY2025 gross margin improvement into structural, mix and one‑off components. If more than a third is one‑off, plan the FY2026 budget on a normalised margin.
3. Review contract cost provisioning. In a year with a client insolvency and renegotiated contracts, ensure that contract cost estimates and any loss provisions have been revisited on all live and recently completed projects.
4. Map the post‑dividend position properly. Produce a pro‑forma balance sheet as at the latest practical date showing net assets, cash and liability cover after the distribution and after subsequent trading. Give this to the board, the auditor and any surety provider.

Short term (6–18 months)

5. Institute client concentration monitoring. Track revenue by client and flag any relationship exceeding, say, 20% of forward order book. Consider credit insurance or project‑specific bonds on the largest exposures.
6. Formalise the working capital engine. The cash conversion in FY2025 was excellent — codify it. Introduce monthly reporting on debtor days, WIP, retentions and subcontractor payables so that a slowdown is visible early.
7. Protect bid capacity. Where prequalification depends on balance sheet strength, prepare a standing pack covering group structure, parent company support, banking arrangements and bonding facilities so that a thinner standalone balance sheet does not cost you invitations to tender.
8. Tighten fixed‑price contract discipline. With price risk explicitly flagged, ensure indexation or fluctuation clauses where possible, and stress‑test tenders against materials and labour inflation.

Medium term (18 months+)

9. Address key‑person and succession risk. The board has been stable for years, which is a strength — but also a concentration. Consider non‑executive representation and documented succession for each director.
10. Diversify sector exposure. The London commercial fit‑out market is cyclical. Adjacent sectors — life sciences, data centres, healthcare, education — use similar skills and would reduce correlation with a single property cycle.
11. Keep the ESG momentum going. A 24% reduction in emissions intensity is a genuine differentiator in client tenders. Continue the fleet transition and formalise targets.
12. Maintain the compliance rhythm. Nothing is overdue and the audit is clean. That is a competitive advantage in a sector where counterparties are scrutinising financial standing more closely than they have in years.